Keywords: LC; liquid chromatography; MS; mass spectrometry; MS/MS; tandem mass spectrometry; UPLC; ultra-high-performance liquid chromatography; MRM; multiple reaction monitoring; ESCC; esophageal squamous cell carcinoma; LC-MS; liquid chromatography-mass spectrome
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cGMP; Retinal ganglion cell; Glaucoma; Nitric oxide; PDE5;
Keywords: AR; adrenergic receptor; cGMP; cyclic guanosine monophosphate; KUB; kidney, ureter, and bladder; MET; medical expulsive therapy; PDE(-5); phosphodiesterase (type 5); USG; ultrasonography; Efficacy; Silodosin; Tadalafil; Tamsulosin; Ureteric calculi;
Keywords: ATP; adenosine triphosphate; BES; biolimus-eluting stents; BMS; bare-metal stent; cGMP; cyclic guanosine monophosphate; DES; drug-eluting stents; DRP 1; dynamin-related protein 1; EES; everolimus eluting stent; eNOS; endothelial NOS; FAD; flavin adenine d
Keywords: Vardenafil; Endothelial dysfunction; Graft; Ischaemia reperfusion injury; cGMP;
Keywords: Bioadhesive suppositories; Conventional suppositories; cGMP; Intravaginal administration; In vitro fertilization; Vardenafil;
Keywords: ER stress; Endothelial dysfunction; Nitric oxide; cGMP; Quercetin; Streptozotocin;
Keywords: Phosphodiesterase-6; Inhibitor; Inhibition constant; Retina; Photoreceptors; Ex vivo electroretinography; A; activation coefficient; cAMP; adenosine 3â²,5â² cyclic monophosphate; cGMP; guanosine 3â²,5â² cyclic monophosphate; CNG channel; cyclic nucleo
Keywords: cGMP; cyclic guanosine monophosphate; DAPI; (4â²,6-Diamidino-2-Phenylindole, Dihydrochloride); EC; endothelial cell; ECs; endothelial cells; eNOS; endothelial nitric oxide synthase; FBS; fetal bovine serum; FITC; Fluorescein isothiocyanate; HAPE; high-al
Keywords: Aging; Age-related cognitive decline; Mild cognitive impairment; Cyclic nucleotides; cAMP; cGMP; Phosphodiesterase; Memory; Alzheimer's disease; Huntington's disease; Parkinson's Disease; Hippocampus; Cortex; Striatum; Cerebellum; PDE1; PDE3; PDE7; PDE8;
Keywords: α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: MD; Mediterranean diet; HT; hydroxytyrosol; IUPAC; International Union of Pure and Applied Chemistry; ADME; absorption, distribution, metabolism and excretion processes; EVOO; extra virgin olive oil; HTA; HT acetate; Tyr; tyrosol; EFSA; European Food Safe
Keywords: cAMP; cyclic adenosine monophosphate; GPCRs; G protein-coupled receptors; GLP-1; glucagon-like peptide 1; ATP; adenosine triphosphate; cGMP; cyclic guanosine monophosphate; Na+/K+/ATPase; sodium-potassium adenosine triphosphatase; TRPC; transient recept
Keywords: AD; Alzheimer's disease; PPs; polyphenols; EGCG; epigallocatechin gallate; NFTs; neurofibrillary tangles; ACh; acetylcholine; Aβ; amyloid-beta; APP; amyloid precursor protein; PS-1; presenilin-1; PS-2; presenilin-2; AChE; acetylcholine esterase; Cdk5;
Keywords: European regulation model; HMP; EU monograph; TUR; WEU-MA; ESCOP; European Scientific Cooperative on Phytotherapy; WHO; World Health Organization; EU; European Union; HMPs; herbal medicinal products; WEU-MAs; marketing authorizations; TURs; traditional us
Keywords: FDA; United States Food and Drug Administration; CGMP; Current Good Manufacturing Proactices; JECFA; Joint FAO/WHO Expert Committee on Food Additives; MRL; maximum residue level; DAL; differential action limit; MT; metric ton; LOTO; Lockout/Tagout; OSHA;
Keywords: cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; Cx43; connexin43; AJ; annular junction; SDS-PAGE; sodium dodecylsulfate-polyacrylamide gel electrophoresis; TPA; 12-O-tetradeconoylphorbol-13-acetate; ZO-1; zonula occludens-1; EG
Keywords: Sitagliptin; BNP; cGMP; PKG; Cyp D;
Keywords: WAT; White adipose tissue; BAT; Brown adipose tissue; UCP-1; Uncoupling protein 1; sWAT; Subcutaneous white adipose tissue; PDE5i; Phosphodiesterase type-5 inhibitor; cGMP; cyclic guanosine monophosphate; TC; Total cholesterol; LDL-C; Low-density lipoprot
Keywords: Structural plasticity; LTP; Actin; Dendritic spines; CaMKII; cAMP; cGMP; Alzheimer's disease; Schizophrenia; ASD;
Keywords: NO; nitric oxide; SNP; sodium nitroprusside; TNG; nitroglycerine; SHR; spontaneously hypertensive rats; TERPY; [Ru(terpy)(bdq)NO]3+; Eâ; endothelium-denuded; E+; endothelium-intact; 2K; sham-operated rats; 2K-1C; two-kidney one-clip, renal hypertensive
Keywords: Phosphodiesterase; Phosphodiesterase inhibitors; cAMP; cGMP; Cancer;
Keywords: Asp-N; endoproteinase AspN; BLA; biologics license application; CDR; complementarity determining region; CFR; Code of Federal Regulations; CGF; carboxyl group footprinting; cGMP; current good manufacturing practice; CHO; Chinese hamster ovary; CID; collis
Keywords: Flavonoids; Quercetin; Plant-derived polyphenol; Cardiovascular action; Bioassay; CVD; Cardiovascular disease; eNOS; endothelial nitric oxide synthase; BcL2; B-cell lymphoma 2; MDA; malonaldehyde; TNFα; tumor necrosis factor α; IL-6; Interleukin 6; PPAR
Keywords: 3-MP; 3-mercaptopyruvate; 3-MST; 3-mercaptopyruvate sulfurtransferase; AAT; aspartate amino transferase; AE1; anion exchanger-1; AGEs; advanced glycation end products; AKI; acute kidney injury; AMPK; AMP-activated protein kinase; AT1; angiotensin receptor
Keywords: 5-HT; serotonin; ABLE; Age of Blood Evaluation; ADP; adenosine diphosphate; ATP; adenosine triphosphate; BC; buffy coat; BTHC; n-butyryl tri-n-hexyl citrate; CCI; corrected count increment; CD; cluster of differentiation; CD40L; CD40 ligand; CD62P; P-sele
Keywords: Apelin; APJ receptors; Elabela; Vasodilation; Vasoconstriction; APJ; apelin receptor; ACE-2; angiotensin converting enzyme type-2; AT-1; angiotensin-1; BKCa; large conductance calcium-activated potassium; CAD; coronary artery disease; cAMP; cyclic adenosi
Keywords: AMA-1; apical membrane antigen 1; 2 -APB; 2-aminoethoxydiphenyl borate; BMP; bis (monoacylglycerol)phosphate; CDP; cytidine diphosphate-choline; cGMP; cyclic guanosine monophosphate; D; aspartate; DAG; diacylglycerol; EBA175; erythrocyte binding antigen 1
Keywords: AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: Atherosclerosis; Cardiovascular diseases; Cell cycle; Proliferation; Pulmonary hypertension; Restenosis; Signaling pathway; Vascular smooth muscle cells; ACE; angiotensin converting enzyme; aFGF; acidic FGF; Ang II; angiotensin II; AP-1; activating protei
Keywords: AGE; Advanced Glycation End products; ALDH2; aldehyde dehydrogenase 2; AngII; angiotensin II; BKCa; large conductance Ca2+-activated K+ channel; Ca2+; calcium; [Ca2+]c; cytosolic free Ca2+ concentration; CaD; caldesmon, CaM, calmodulin; cAMP; cyclic adeno
Keywords: ANP; atrial natriuretic peptide; Arg(Me); NÏ-methylarginine; cGMP; cyclic guanosine monophosphate; Cha; 3-cyclohexylalanine; GC; guanylate cyclase; hANP; human ANP; Hyp; trans-4-hydroxyproline; LC/MS/MS; liquid chromatography-tandem mass spectrometry;
Keywords: Combination products; Biologics; Design controls; Medical device; FDA; CGMP; Quality systems;
Keywords: ANP; atrial natriuretic peptide; AUC; The area under the plasma concentration-time curve; BNP; brain natriuretic peptide; cGMP; Cyclic guanosine monophosphate; CHO; Chinese hamster ovary; CNP; C-type natriuretic peptide; CNS; the central nervous system; G
Keywords: AMPK; AMP-activated protein kinase; cGMP; cyclic guanosine monophosphate; EDH; endothelium-dependent hyperpolarization; H2O2; hydrogen peroxide; NO; nitric oxide; NOS; nitric oxide synthase; PGs; prostaglandins; PKG; cGMP-dependent protein kinase; ROS; re
Keywords: Vaccine production; Developing-country; Manufacturer viability; cGMP; current Good Manufacturing Practice; DCVM; developing-country vaccine manufacturer; EPI; Expanded Programme on Immunization; MNC; multinational corporation; NRA; national regulatory aut
Keywords: Asafoetida; Essential oil; Vasodilatory effect; Nitric oxide; Cyclooxygenase; Aorta rings; AEO; Asafoetida essential oil; KCl; potassium chloride; NO; nitric oxide; COX; cyclooxygenase; L-NAME; L-NG-Nitroarginine methyl ester; CaCl2; calcium chloride; IC5
Keywords: ATPS; aqueous two-phase extraction; cGMP; current good manufacturing practice; CHO; Chinese hamster ovary; HCP; host cell protein; HIV/AIDS; human immunodeficiency virus/acquired immunodeficiency syndrome; mAb; monoclonal antibody; SMB; simulated moving b
Polar silica-based stationary phases. Part II- Neutral silica stationary phases with surface bound maltose and sorbitol for hydrophilic interaction liquid chromatography
Keywords: 2AB; 2-aminobenzamide; ACN; acetonitrile; cAMP; adenosine 2â²:3â²-cyclic monophosphate; cGMP; guanosine 2â²:3â²-cyclic monophosphate; CMP; cytidine 5â²-monophosphate; cUMP; uridine 2â²:3â²-cyclic monophosphate; DMF; N,N-dimethylformamide; GMP; guan
Keywords: cAMP; 3â²,5â²-cyclic adenosine monophosphate; β-AR; β-adrenergic receptor; cGMP; 3â²,5â²-cyclic guanosine monophosphate; FRET; Förster resonance energy transfer; IBMX; 3-isobutyl-1-methylxanthine; ISO; isoproterenol; PDE; phosphodiesterase; SICM; s
Keywords: BDS; bulk drug substance; BPL; β-propiolactone; cGMP; current good manufacturing practices; DENV; dengue virus; DP; drug product; Env; envelope protein; FFA; focus forming assay; GLP; good laboratory practices; H2O2; hydrogen peroxide; IVRP; in vitro rel
Keywords: AMG; Aminoguanidine; APE/Ref-1; Apurinic/apyrimidinic endonuclease-1/redox factor-1; ARG1; Arginine 1; BCL2; B-cell lymphoma 2 gene; BRAF; B- Rapidly Accelerated Fibrosarcoma; cGMP; Cyclic guanosine monophosphate; cNOS; constitutional nitric oxide synthas
Keywords: CAD; coronary artery diseases; DIC; disseminated intravascular coagulation, I/R, ischemia/reperfusion; MPI; myocardial perfusion imaging; SCI; spinal cord injury; ED; erectile dysfunction; AUC; area under the concentration-time curve; cAMP; cyclic adenosi
Keywords: basal cell carcinoma; melanoma; meta-analysis; PDE5 inhibitor; squamous cell carcinoma; BCC; basal cell carcinoma; cGMP; cyclic guanosine-3â²,5â²-monophosphate; CI; confidence interval; NOS; Newcastle-Ottawa quality-assessment scale; OR; odds ratio; PDE
Keywords: aAPC; artificial APC; ACT; adoptive cell therapy; CDM; chemically defined media; cGMP; current Good Manufacturing Practices; DC; dendritic cell; CPP; critical process parameter; CQA; critical quality attribute; FACS; fluorescence activated cell sorting; H
Keywords: Biotin; Soluble guanylate cyclase; Cgmp; Protein kinase G; Multiple sclerosis; Schwann cells; Neurotrophic factors; Alzheimers disease; Beta-amyloid; Phosphodiesterase-5;
Keywords: cGMP; cyclic Guanine Monophosphate; CPTIO; 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide potassium; DAF-2 DA; 4,5-diaminofluorescein diacetate; DB/DB; Diabetic mouse strain with deletion of leptin receptor; DNIC; Dinitrosyl iron comple
Keywords: Sildenafil; Tadalafil; Platelets; cGMP; LC-MS/MS;
Keywords: EPT; enzyme prodrug therapy; NSC; neural stem cells; MSC; mesenchymal stromal cells; NK; natural killer cells; iPSCs; induced pluripotent stem cells; HSV-TK; herpes simplex virus thymidine kinase; GCV; ganciclovir; 5-FC; 5-Flurocytosine; 5-FU; 5-Flurouric
Keywords: AMOT; Angiomotin; cGMP; cyclic guanosine monophosphate; DLC1; deleted in liver cancer 1; ECM; extracellular matrix; eNOS; endothelial nitric oxide synthase; FA; focal adhesion; HGF; hepatocyte growth factor; HSC; shepatic stellate cells; ILK; integrin lin